Close

Stem cell trials in the news

Reading Time: 4 minutes The recent announcement about the use of stem cells to treat a form of multiple sclerosis (MS), together with early results from the BrainStorm stem cell amyotrophic lateral sclerosis (ALS) clinical trial in Israel have raised the profile of stem cells as a possible treatment for motor neurone disease. Stem cells are unspecialised cells in…

Clinical trials update from Symposium

Reading Time: 5 minutes Clinical trials determine if potential treatments are safe and aim to prove beyond reasonable doubt whether a drug is beneficial. They are therefore the gold standard of treatment research. More information on the different types of clinical trial can be found on our website and in our information sheet on the topic. This year the…

Tirasemtiv Phase II clinical trial – results

Reading Time: 4 minutes The top-line results from the Cytokinetics Inc Phase IIb clinical trial of Tirasemtiv were announced last week. Following this announcement, detailed results were then presented on 29 April 2014 at the Annual Academy of Neurology (AAN) meeting. Unfortunately, although the drug was found to be safe, the results concluded that Tirasemtiv did not meet its…

Antisense seems to make sense

Reading Time: 3 minutes Results from a phase I clinical trial of a drug known as ISIS 333611 have been published open-access online in the scientific journal Lancet Neurology on 29 March 2013. This is the first time researchers have tested the effects of delivering an antisense oligonucleotide directly into the human cerebral spinal fluid (the fluid between the spinal…